Cheung CMG, Lee WK, Koizumi H, Dansingani K, Lai TYY, Freund KB. Pachychoroid disease. Eye. 2019;33:14–33.
Nicholson B, Noble J, Forooghian F, Meyerle C. Central serous chorioretinopathy: update on pathophysiology and treatment. Surv Ophthalmol. 2013;58:103–26.
Article PubMed PubMed Central Google Scholar
Iovino C, Au A, Chhablani J, Parameswarappa DC, Rasheed MA, Cennamo G, et al. Choroidal Anatomic Alterations After Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: A Multicenter Study. Am J Ophthalmol. 2020;217:104–13.
Christou EE, Katsanos A, Georgalas I, Kozobolis V, Kalogeropoulos C, Stefaniotou M. The Choroid after Half-Dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy. Acta Med. 2022;65:89–98.
Lim LS, Cheung G, Lee SY. Comparison of spectral domain and swept-source optical coherence tomography in pathological myopia. Eye. 2014;28:488–91.
Article CAS PubMed PubMed Central Google Scholar
Betzler BK, Ding J, Wei X, Lee JM, Grewal DS, Fekrat S, et al. Choroidal vascularity index: a step towards software as a medical device. Br J Ophthalmol. 2022;106:149–55.
Ruiz-Moreno JM, Gutiérrez-Bonet R, Chandra A, Vupparaboina KK, Chhablani J, Ruiz-Medrano J. Choroidal Vascularity Index versus Choroidal Thickness as Biomarkers of Acute Central Serous Chorioretinopathy. Ophthalmic Res. 2023;66:627–35.
Article CAS PubMed Google Scholar
Agrawal R, Chhablani J, Tan KA, Shah S, Sarvaiya C, Banker A. Choroidal vascularity index in central serous chorioretinopathy. Retin. 2016;36:1646–51.
Stanga PE, Tsamis E, Papayannis A, Stringa F, Cole T, Jalil A. Swept-Source Optical Coherence Tomography Angio™ (Topcon Corp, Japan): Technology Review. Dev Ophthalmol. 2016;56:13–7.
Agrawal R, Wei X, Goud A, Vupparaboina KK, Jana S, Chhablani J. Influence of scanning area on choroidal vascularity index measurement using optical coherence tomography. Acta Ophthalmol. 2017;95:e770–e5.
Agrawal R, Seen S, Vaishnavi S, Vupparaboina KK, Goud A, Rasheed MA, et al. Choroidal Vascularity Index Using Swept-Source and Spectral-Domain Optical Coherence Tomography: A Comparative Study. Ophthalmic Surg Lasers Imaging Retin. 2019;50:e26–e32.
Copete S, Flores-Moreno I, Montero JA, Duker JS, Ruiz-Moreno JM. Direct comparison of spectral-domain and swept-source OCT in the measurement of choroidal thickness in normal eyes. Br J Ophthalmol. 2014;98:334–8.
Ting DS, Cheung GC, Lim LS, Yeo IY. Comparison of swept source optical coherence tomography and spectral domain optical coherence tomography in polypoidal choroidal vasculopathy. Clin Exp Ophthalmol. 2015;43:815–9.
Benov L. Photodynamic therapy: current status and future directions. Med Princ Pract. 2015;24 Suppl 1:14–28.
Erikitola OC, Crosby-Nwaobi R, Lotery AJ, Sivaprasad S. Photodynamic therapy for central serous chorioretinopathy. Eye. 2014;28:944–57.
Article CAS PubMed PubMed Central Google Scholar
Altinel MG, Kanra AY, Totuk OMG, Ardagil A, Kabadayi K. Comparison of half-dose versus half-fluence versus standard photodynamic therapy in chronic central serous chorioretinopathy. Photodiagnosis Photodyn Ther. 2021;33:102081.
Article CAS PubMed Google Scholar
Sevik MO, Aykut A, Çam F, Dericioğlu V, Şahin Ö. Choroidal vascularity index as an activity criterion and a treatment response measure in chronic central serous chorioretinopathy. Ophthalmic Physiol Opt. 2023;43:1203–10.
Karasu B, Akbas YB, Aykut A, Celebi ARC. Comparison of Retinochoroidal Vascular and Structural Changes after Half-Dose Photodynamic Therapy versus Half-Fluence Photodynamic Therapy Based on Optical Coherence Tomography Angiography in Eyes with Chronic Central Serous Chorioretinopathy. Ophthalmologica. 2022;245:323–34.
Article CAS PubMed Google Scholar
Manabe S, Shiragami C, Hirooka K, Izumibata S, Tsujikawa A, Shiraga F. Change of regional choroid thickness after reduced-fluence photodynamic therapy for chronic central serous chorioretinopathy. Am J Ophthalmol. 2015;159:644–51.
van Rijssen TJ, Singh SR, van Dijk EHC, Rasheed MA, Vupparaboina KK, Boon CJF, et al. Prospective evaluation of changes in choroidal vascularity index after half-dose photodynamic therapy versus micropulse laser treatment in chronic central serous chorioretinopathy. Graefe’s Arch Clin Exp Ophthalmol. 2020;258:1191–7.
Park W, Kim M, Kim RY, Park YH. Comparing effects of photodynamic therapy in central serous chorioretinopathy: full-dose versus half-dose versus half-dose-half-fluence. Graefes Arch Clin Exp Ophthalmol. 2019;257:2155–61.
Article CAS PubMed Google Scholar
Izumi T, Koizumi H, Maruko I, Takahashi Y, Sonoda S, Sakamoto T, et al. Structural analyses of choroid after half-dose verteporfin photodynamic therapy for central serous chorioretinopathy. Br J Ophthalmol. 2017;101:433–7.
Midorikawa M, Mori K, Torii H, Tomita Y, Zhang Y, Tsubota K, et al. Choroidal thinning in myopia is associated with axial elongation and severity of myopic maculopathy. Sci Rep. 2024;14:17600.
Article CAS PubMed PubMed Central Google Scholar
Yang J, Wang E, Yuan M, Chen Y. Three-dimensional choroidal vascularity index in acute central serous chorioretinopathy using swept-source optical coherence tomography. Graefes Arch Clin Exp Ophthalmol. 2020;258:241–7.
Sahoo NK, Singh SR, Beale O, Nkrumah G, Rasheed MA, Jabeen A, et al. Choroidal Vascularity Map in Unilateral Central Serous Chorioretinopathy: A Comparison with Fellow and Healthy Eyes. Diagnostics. 2021;11:861.
Comments (0)